Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer

Although there are molecularly distinct subtypes of prostate cancer, no molecular classification system is used clinically. The ribonucleotide reductase small subunit M2 (RRM2) gene plays an oncogenic role in many cancers. Our previous study elucidated comprehensive molecular mechanisms of RRM2 in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazzu, Ying Z., Armenia, Joshua, Nandakumar, Subhiksha, Chakraborty, Goutam, Yoshikawa, Yuki, Jehane, Lina E., Lee, Gwo‐Shu Mary, Atiq, Mohammad, Khan, Nabeela, Schultz, Nikolaus, Kantoff, Philip W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400792/
https://www.ncbi.nlm.nih.gov/pubmed/32385899
http://dx.doi.org/10.1002/1878-0261.12706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400792/
https://www.ncbi.nlm.nih.gov/pubmed/32385899
http://dx.doi.org/10.1002/1878-0261.12706

Ejemplares similares